Review
doi: 10.7189/jogh.10.010358.
The case for compulsory licensing during COVID-19
Affiliations
- PMID: 32509289
- PMCID: PMC7242884
- DOI: 10.7189/jogh.10.010358
Item in Clipboard
Review
The case for compulsory licensing during COVID-19
J Glob Health.
2020 Jun.
No abstract available
Conflict of interest statement
Competing interests: The author has completed the ICMJE uniform disclosure form (available upon request) and declares no conflicts of interest.
Figures
Photo: HIV antiretroviral medication by NIAID on Wikimedia Commons.
Similar articles
-
Compulsory licensing of generic drugs remains mired in quagmires.CMAJ. 2011 Aug 9;183(11):E705-6. doi: 10.1503/cmaj.109-3898. Epub 2011 Jun 27. CMAJ. 2011. PMID: 21708968 Free PMC article. No abstract available.
-
COVID-19: save lives with open intellectual-property licences.Nature. 2020 Jul;583(7818):683. doi: 10.1038/d41586-020-02233-4. Nature. 2020. PMID: 32724145 No abstract available.
-
Compulsory licensing and access to drugs.Eur J Health Econ. 2015 Jan;16(1):83-94. doi: 10.1007/s10198-013-0556-2. Epub 2014 Jan 10. Eur J Health Econ. 2015. PMID: 24408475
-
Is Compulsory Licensing Bad for Public Health? Some Critical Comments on Drug Accessibility in Developing Countries.Appl Health Econ Health Policy. 2017 Oct;15(5):557-565. doi: 10.1007/s40258-017-0306-1. Appl Health Econ Health Policy. 2017. PMID: 28120166 Review.
-
The need to implement non-industry COVID-19 clinical trials in non-high-income countries.J Glob Health. 2020 Jun;10(1):010351. doi: 10.7189/jogh.10.010351. J Glob Health. 2020. PMID: 32509284 Free PMC article. Review. No abstract available.
Cited by
-
Breaking Bad Patents: Learning from HIV/AIDS to make COVID-19 treatments accessible.Glob Public Health. 2021 Oct;16(10):1523-1536. doi: 10.1080/17441692.2021.1924223. Epub 2021 May 8. Glob Public Health. 2021. PMID: 33966604 Free PMC article. Review.
-
The role of patent waivers and compulsory licensing in facilitating access to COVID-19 vaccines: Findings from a survey among healthcare practitioners in Nigeria.PLOS Glob Public Health. 2022 Jul 7;2(7):e0000683. doi: 10.1371/journal.pgph.0000683. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962435 Free PMC article.
-
Breathing fresh air into the debate: Ventilators and the United States' intellectual property problem.Health Policy Open. 2022 Apr 7;3:100069. doi: 10.1016/j.hpopen.2022.100069. eCollection 2022 Dec. Health Policy Open. 2022. PMID: 37383575 Free PMC article.
-
Pandemic treaty as an instrument to strengthen global health security: Global health diplomacy at its crux.Health Promot Perspect. 2024 Mar 14;14(1):9-18. doi: 10.34172/hpp.42744. eCollection 2024 Mar. Health Promot Perspect. 2024. PMID: 38623344 Free PMC article. Review.
-
Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis.Front Public Health. 2022 Jul 22;10:928065. doi: 10.3389/fpubh.2022.928065. eCollection 2022. Front Public Health. 2022. PMID: 35937225 Free PMC article.
References
-
- FAIR Health. The Projected Economic Impact of the COVID-19 Pandemic on the US Healthcare System. New York: FAIR Health, Inc.; 2020.
-
- World Trade Organization. Agreement on Trade-Related Aspects of Intellectual Property Rights, 15 Apr. 1994. Available: https://www.wto.org/english/docs_e/legal_e/27-trips.pdf. Accessed: 19 March 2020.
-
- Stiglitz J. Making Globalization Work: The next Steps to Global Justice. London: Penguin; 2007.
-
- World Trade Organization. Declaration on the TRIPS Agreement and Public Health, 20 Nov. 2001. Available: http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm. Accessed: 23 March 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
